Evidence map›Paper›PMID 37596622›Full record

ArticleVirology journal2023

Influenza a virus regulates interferon signaling and its associated genes; MxA and STAT3 by cellular miR-141 to ensure viral replication.

Mai Alalem, Emad Dabous, Ahmed M Awad, Nedaa Alalem, Adel A Guirgis, Samir El-Masry, Hany Khalil

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Epigallocatechin-3-gallate inhibits replication of influenza A virus via restoring the host methylated genes following infection.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mai AlalemDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt.
Emad DabousDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt.
Ahmed M AwadDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt.
Nedaa AlalemDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt.
Adel A GuirgisDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt.
Samir El-MasryDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt.
Hany KhalilDepartment of Molecular Biology, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, 79, Egypt. hany.khalil@gebri.usc.edu.eg.
University of Sadat City · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antiviral response against influenza A virus (IAV) infection includes the induction of the interferon (IFN) signaling pathway, including activation of the STATs protein family. Subsequently, antiviral myxovirus resistance (MxA) protein and other interferon-stimulated genes control virus replication; however, the molecular interaction of viral-mediated IFN signaling needs more investigation. Host microRNAs (miRNAs) are small non-coding molecules that posttranscriptionally regulate gene expression. Here, we sought to investigate the possible involvement of miR-141 in IAV-mediated IFN signaling. Accordingly, the microarray analysis of A549 cells transfected with precursor miR-141 (pre-miR-141) was used to capture the potentially regulated genes in response to miR-141 overexpression independent of IAV infection. The downregulation of targeted genes by miR-141, in addition to viral gene expression, was investigated by quantitative real-time PCR, western blot analysis, and flow cytometric assay. Our findings showed a significant upregulation of miR-141 in infected A549 cells with different strains of IAV. Notably, IAV replication was firmly interrupted in cells transfected with the miR-141 inhibitor. While its replication significantly increased in cells transfected with pre-miR-141 confirming the crucial role of miRNA-141 in supporting virus replication. Interestingly, the microarray data of miR-141 transduced A549 cells showed many downregulated genes, including MxA, STAT3, IFI27, and LAMP3. The expression profile of MxA and STAT3 was significantly depleted in infected cells transfected with the pre-miR-141, while their expression was restored in infected cells transfected with the miR-141 inhibitor. Unlike interleukin 6 (IL-6), the production of IFN-β markedly decreased in infected cells that transfected with pre-miR-141, while it significantly elevated in infected cells transfected with miR-141 inhibitor. These data provide evidence for the crucial role of miR-141 in regulating the antiviral gene expression induced by IFN and IL-6 signaling during IAV infection to ensure virus replication.

Indexed as

Influenza A virusInfluenza, HumanMicroRNAsAntiviral AgentsHumansInterferonsInterleukin-6Myxovirus Resistance ProteinsSignal TransductionSTAT3 Transcription FactorAntiviral AgentsInterferonsInterleukin-6MicroRNAsMIRN141 microRNA, humanMX1 protein, humanMyxovirus Resistance ProteinsSTAT3 protein, humanSTAT3 Transcription FactorIAVIFN-β signalingIL-6miR-141MxA geneSTAT3

Identifiers

PMID37596622
PMCPMC10439583
OpenAlexW4385986454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.